Lilly noted in a press release that at 80 weeks, all the doses of retatrutide met the primary and key secondary endpoints for obesity, delivering clinically meaningful weight loss. TRIUMPH-1 highlights the importance of options and the potential for retatrutide to help people across various stages of their obesity journey, Kenneth Custer, PhD, executive vice president and president, Lilly Cardiometabolic Health, said in a press release
in diabetic and lipid-disordered mice, supplementation with an alcohol clove extract resulted in lower glucose, triglyceride, free fatty acid, HbA1C levels (Sanae 2014)
PMID: 16539679 Khvatova EM, Samartzev VN, Zagoskin PP, Prudchenko IA, Mikhaleva II (2003) Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypoxia
Six months in, my A1C is back to normal and Im down 31 pounds
Contact Richardson Pain & Wellness and schedule an appointment with us today
In the future, more attention should be paid to the long-term safety and efficacy of targeted drugs in future clinical studies